Cargando…

Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease

BACKGROUND: Peripheral artery disease (PAD) is associated with heightened risk for major adverse cardiovascular and limb events, but data on the burden of risk for total (first and potentially subsequent) events, and the association with polyvascular disease, are limited. This post hoc analysis of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szarek, Michael, Hess, Connie, Patel, Manesh R., Jones, W. Schuyler, Berger, Jeffrey S., Baumgartner, Iris, Katona, Brian, Mahaffey, Kenneth W., Norgren, Lars, Blomster, Juuso, Rockhold, Frank W., Hsia, Judith, Fowkes, F. Gerry R., Bonaca, Marc P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238734/ https://www.ncbi.nlm.nih.gov/pubmed/35621222 http://dx.doi.org/10.1161/JAHA.122.025504

Ejemplares similares

Understanding Study Drug Discontinuation Through EUCLID
por: Weissler, E. Hope, et al.
Publicado: (2022)

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial
por: Norgren, Lars, et al.
Publicado: (2021)

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
por: Galani, Jemi, et al.
Publicado: (2021)

Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID
por: Samsky, Marc D., et al.
Publicado: (2021)

Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease
por: Adam, Luise, et al.
Publicado: (2023)

Polyvascular Disease and the Incidence of Cancer in Patients with Coronary Artery Disease
por: Suzuki, Makoto, et al.
Publicado: (2022)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

Comprehensive Assessment of Polyvascular Atherosclerosis
por: Nakanishi, Rine, et al.
Publicado: (2018)

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization
por: Hess, Connie N., et al.
Publicado: (2022)

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023)

Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD
por: Hess, Connie N., et al.
Publicado: (2022)

Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke
por: Ma, Lin, et al.
Publicado: (2021)

Preclinical carotid atherosclerosis as an indicator of polyvascular disease: a narrative review
por: Poredos, Pavel, et al.
Publicado: (2021)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes
por: Al Thani, Hassan, et al.
Publicado: (2012)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study
por: Dikilitas, Ozan, et al.
Publicado: (2020)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
por: Funabashi, Sayaka, et al.
Publicado: (2022)

Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy – case report and review of the literature
por: Jurcut, R, et al.
Publicado: (2009)

Association of Polyvascular Disease and Elevated Interleukin-6 With Outcomes in Acute Ischemic Stroke or Transient Ischemic Attack
por: Tian, Ye, et al.
Publicado: (2021)

Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease
por: Jönelid, Birgitta, et al.
Publicado: (2019)

Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access
por: Yamawaki, Masahiro, et al.
Publicado: (2021)

Circulating Ageing Neutrophils as a Marker of Asymptomatic Polyvascular Atherosclerosis in Statin-Naïve Patients without Established Cardiovascular Disease
por: Genkel, Vadim, et al.
Publicado: (2022)

Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
por: Zhou, Yong, et al.
Publicado: (2013)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial
por: Hess, Connie N., et al.
Publicado: (2022)

Lower extremity amputation in peripheral artery disease: improving patient outcomes
por: Swaminathan, Aparna, et al.
Publicado: (2014)

Correction: Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
por: Zhou, Yong, et al.
Publicado: (2014)

Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor–Treated Patients: Reconciling Adjudicated and Coded Outcomes
por: Kondapalli, Lavanya, et al.
Publicado: (2022)

Carotid Atherosclerosis, Cerebrospinal Fluid Pressure, and Retinal Vessel Diameters: The Asymptomatic Polyvascular Abnormalities in Community Study
por: Yang, Jing Yan, et al.
Publicado: (2016)

Impact of polyvascular disease with and without co‐existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA‐REG OUTCOME
por: Verma, Subodh, et al.
Publicado: (2021)

The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease
por: Tsai, Thomas T., et al.
Publicado: (2015)

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease
por: Biswas, Minakshi P., et al.
Publicado: (2021)

The prevalence of carotid plaque with different stability and its association with metabolic syndrome in China: The Asymptomatic Polyvascular Abnormalities Community study
por: Wang, Anxin, et al.
Publicado: (2016)

Occurrence and mortality of vasospastic angina pectoris hospitalised patients in Finland: a population-based registry cohort study
por: Pikkarainen, Essi, et al.
Publicado: (2019)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
por: Canonico, Mario Enrico, et al.
Publicado: (2023)

Assessing an Electronic Health Record research platform for identification of clinical trial participants
por: Laaksonen, Niina, et al.
Publicado: (2020)

Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
por: Swaminathan, Rajesh V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hfope6ltag7itt0sfhpet8gf8u